Pentixapharm Holding AG (PTP)

PRESS RELEASE

published on 11/21/2024 at 13:41, 1 month ago

Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Pentixapharm Holding AG gibt den Start der klinischen Studie PENTILULA bekannt, um AML und ALL zu behandeln. Analysten bestätigen Kaufempfehlung und Kursziel. Neue Therapie mit Lutetium-177

Pentixapharm Holding AG Lutetium-177 PENTILULA AML ALL
BRIEF

published on 11/21/2024 at 11:05, 1 month ago

Pentixapharm fait progresser les essais cliniques pour le traitement de la leucémie

Essai Clinique Produits Radiopharmaceutiques Pentixapharm Lu-177 Traitement De La Leucémie
BRIEF

published on 11/21/2024 at 11:05, 1 month ago

Pentixapharm Advancing Clinical Trials for Leukemia Treatment

Clinical Trial Radiopharmaceuticals Pentixapharm Lu-177 Leukemia Treatment
PRESS RELEASE

published on 11/21/2024 at 11:00, 1 month ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Pentixapharm starts Phase I/II trial treating leukemia with Lu177-PentixaTher, a targeted radiotherapy. Study aims to expand treatment options for hematologic malignancies

Phase I/II Trial Leukemia Pentixapharm Radiotherapy Lu177-PentixaTher
BRIEF

published on 11/12/2024 at 17:50, 1 month 9 days ago

Pentixapharm publie ses résultats intermédiaires du troisième trimestre 2024

Perte Financière Spin Off Rapport Intérimaire Pentixapharm Troisième Trimestre
BRIEF

published on 11/12/2024 at 17:50, 1 month 9 days ago

Pentixapharm Reports Third Quarter 2024 Interim Results

Interim Report Spin-off Financial Loss Third Quarter Pentixapharm
PRESS RELEASE

published on 11/12/2024 at 17:45, 1 month 9 days ago

Pentixapharm Releases Interim Report for the Third Quarter of 2024
Pentixapharm Holding AG releases interim report for third quarter of 2024, reporting a loss of €49k with no revenue. Anticipates significant increase in losses for 2024 consolidated annual financial statements

Financial Statements Revenue Interim Report Loss Pentixapharm
BRIEF

published on 11/04/2024 at 17:31, 1 month 17 days ago

Pentixapharm salue l'amélioration du remboursement des produits radiopharmaceutiques par le CMS

Produits Radiopharmaceutiques Pentixapharm Décision Du CMS Politique De Remboursement Innovation Diagnostique
BRIEF

published on 11/04/2024 at 17:31, 1 month 17 days ago

Pentixapharm Applauds CMS Reimbursement Enhancement for Radiopharmaceuticals

Radiopharmaceuticals Pentixapharm CMS Decision Reimbursement Policy Diagnostic Innovation
PRESS RELEASE

published on 11/04/2024 at 17:26, 1 month 17 days ago

Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals
Pentixapharm welcomes CMS decision to enhance reimbursement for diagnostic radiopharmaceuticals, which could impact future streams for Ga68-PentixaFor and have broader market implications

Radiopharmaceuticals Reimbursement Pentixapharm Ga68-PentixaFor CMS Decision

1 2 ... 4

Published on 12/21/2024 at 01:30, 16 hours 21 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 16 hours 21 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 17 hours 46 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 17 hours 51 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 18 hours 21 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 17 hours ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 17 hours 6 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 22 hours 40 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 22 hours 55 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 23 hours 51 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 5 hours 33 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 5 hours 33 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 23 hours 51 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 23 hours 51 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 23 hours 56 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News